|
시장보고서
상품코드
2055112
복수 시장 : 복수 유형별, 중증도별, 치료 유형별, 임상 등급별, 투여 경로별, 유통 채널별, 최종사용자별, 지역별Ascites Market, By Ascites Type, By Ascites Severity, By Treatment Type, By Clinical Grade, By Route of Administration, By Distribution Channel, By End User, By Geography |
||||||
복수 시장은 2026년 15억 8,000만 달러로 추정되고, 2033년까지 24억 9,000만 달러에 이를 것으로 예상되고 있습니다. 또한 2026-2033년 CAGR 6.7%를 기록할 전망입니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준연도 : | 2025년 | 2026년 시장 규모 : | 15억 8,000만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 예측 기간(2026-2033년) CAGR : | 6.70% | 2033년 시장 규모 예측 : | 24억 9,000만 달러 |
세계 복수 시장은 광범위한 치료 분야에서 중요한 부문으로, 복강 내 비정상적인 체액 축적이 특징인 심각한 질환을 다루는 분야입니다.
복수는 주로 간경변의 합병증으로 나타나며, 전체 증례의 약 80%를 차지하지만, 악성 종양, 심부전, 신장 질환 및 기타 기저 질환에 의해서도 발생할 수 있습니다. 이 분야에는 이뇨제, 천자 배액, 경경정맥 간내 문맥-체순환 단락술(TIPS), 복막정맥 단락술, 중증 환자의 간 이식 등 다양한 치료법이 포함됩니다.
간 질환, 특히 비알코올성 지방간 질환(NAFLD) 및 알코올성 간 질환의 유병률 증가에 더해, 전 세계적으로 B형 및 C형 간염 감염 사례가 증가하고 있는 것이 복수 관리가 필요한 환자 수 증가에 크게 기여하고 있습니다. 또한, 전 세계적인 고령화와 악성 복수를 유발할 가능성이 있는 각종 암의 발병률 증가가 시장 규모를 더욱 확대시키고 있습니다.
세계 의료계는 복수가 환자와 의료 자원 모두에 미치는 막대한 부담을 인식하고 있으며, 이에 따라 보다 효과적인 진단 도구, 치료법 및 관리 전략에 대한 수요가 증가하고 있습니다. 시장은 최소 침습 시술의 기술적 진보, 신약 개발, 그리고 진단 영상 기술의 발전에 따라 지속적으로 진화하고 있습니다.
시장 역학
세계 복수 시장은 지속적인 성장 궤도에 기여하는 몇 가지 주요 시장 성장 촉진요인에 힘입어 성장하고 있습니다. 주요 시장 성장 요인은 전 세계 간경변 유병률의 급증에 있으며, 이는 알코올 소비량 증가, 바이러스성 간염 감염, 그리고 비만 및 당뇨병과 관련된 비알코올성 지방간 질환의 급속한 확산에 의해 가속화되고 있습니다.
선진국과 개발도상국에서 의료비가 증가함에 따라, 첨단 진단법과 다양한 치료 옵션에 대한 접근성이 향상되고 있습니다. 한편, 천자술과 초음파 유도 시술 기술의 발전, 그리고 새로운 이뇨제 제제의 개발로 인해 환자의 예후와 치료 효과가 개선되고 있습니다. 그러나 시장에는 성장 가능성을 저해할 수 있는 중대한 제약 요인이 존재합니다.
TIPS(경정맥 문맥계 샛길)나 간이식 같은 고도의 시술에 수반되는 고액의 치료비는 특히 의료 인프라가 제한적인 신흥 경제국에서 치료 접근의 장벽이 되고 있습니다. 특정 시술의 침습성이나 감염 위험, 전해질 이상 등의 합병증은 종종 환자의 치료 순응도를 저해하거나 의사의 권고를 따르지 못하게 하는 요인이 됩니다.
또한, 의료 시스템 간에 표준화된 치료 프로토콜이 부재한 점과 특정 지역에서 조기 진단 및 관리에 대한 인식 부족 또한 큰 과제로 대두되고 있습니다. 이러한 제약이 있음에도 불구하고, 시장 상황에는 큰 기회가 존재합니다. 맞춤형 의료에 대한 관심이 높아지고 있으며, 복수를 유발하는 기저 질환에 대한 표적 치료법의 개발은 제약 기업들에게 유망한 전망을 제시하고 있습니다. 아시아태평양과 라틴아메리카의 신흥 시장에서는 의료 인프라의 개선과 의료 의식의 고취로 인해 큰 성장 가능성이 예상됩니다.
본 조사의 주요 특징
- 본 조사에서는 각 부문의 잠재적 수익 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한, 본 조사에서는 시장 성장 촉진요인, 시장 성장 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업들이 채택하는 경쟁 전략에 관한 중요한 인사이트를 제공합니다.
- 본 조사에서는 다음 매개변수를 바탕으로 전 세계 복수 시장의 주요 기업 프로파일을 작성했습니다. 기업 개요, 제품 포트폴리오, 주요 성과, 재무 실적 및 전략.
- 본 보고서의 인사이트를 활용함으로써, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대 및 마케팅 전략에 관해 정보에 기반한 의사결정을 내릴 수 있게 됩니다.
- 본 세계의 복수 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진출기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계 복수 시장 분석에 활용되는 다양한 전략 매트릭스를 통해 의사결정을 수월하게 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 복수 시장 : 복수 유형별, 2021년-2033년
제5장 세계의 복수 시장 : 중증도별, 2021년-2033년
제6장 세계의 복수 시장 : 치료 유형별, 2021년-2033년
제7장 세계의 복수 시장 : 임상 등급별, 2021년-2033년
제8장 세계의 복수 시장 : 투여 경로별, 2021년-2033년
제9장 세계의 복수 시장 : 유통 채널별, 2021년-2033년
제10장 세계의 복수 시장 : 최종사용자별, 2021년-2033년
제11장 세계의 복수 시장 : 지역별, 2021년-2033년
제12장 경쟁 구도
제13장 애널리스트의 제안
제14장 참고 문헌 및 조사 방법
LSH 26.06.23Ascites Market is estimated to be valued at USD 1.58 Bn in 2026 and is expected to reach USD 2.49 Bn by 2033, growing at a compound annual growth rate (CAGR) of 6.7% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 1.58 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 6.70% | 2033 Value Projection: | USD 2.49 Bn |
The global ascites market represents a critical segment within the broader therapeutic landscape, addressing a serious medical condition characterized by abnormal fluid accumulation in the peritoneal cavity.
Ascites primarily manifests as a complication of liver cirrhosis, accounting for approximately 80% of cases, though it can also result from malignancies, heart failure, kidney disease, and other underlying pathological conditions. This market encompasses various treatment modalities including diuretics, paracentesis procedures, transjugular intrahepatic portosystemic shunt (TIPS), peritoneovenous shunts, and liver transplantation in severe cases.
The increasing prevalence of liver diseases, particularly non-alcoholic fatty liver disease (NAFLD) and alcoholic liver disease, coupled with rising cases of hepatitis B and C infections globally, has significantly contributed to the growing patient population requiring ascites management. Additionally, the aging global population and increasing incidence of various cancers that can lead to malignant ascites have further expanded the market scope.
Healthcare systems worldwide are recognizing the substantial burden that ascites places on both patients and healthcare resources, driving demand for more effective diagnostic tools, therapeutic interventions, and management strategies. The market continues to evolve with technological advancements in minimally invasive procedures, development of novel pharmaceutical agents, and improved diagnostic imaging techniques.
Market Dynamics
The global ascites market is propelled by several key drivers that collectively contribute to its sustained growth trajectory. The primary driver stems from the escalating prevalence of liver cirrhosis worldwide, fueled by increasing alcohol consumption, viral hepatitis infections, and the rapidly growing epidemic of non-alcoholic fatty liver disease associated with obesity and diabetes.
Rising healthcare expenditure in developed and developing nations has enhanced access to advanced diagnostic procedures and treatment options, while technological innovations in paracentesis techniques, ultrasound-guided procedures, and development of novel diuretic formulations have improved patient outcomes and treatment efficacy. However, the market faces significant restraints that could impede its growth potential.
High treatment costs associated with advanced procedures like TIPS and liver transplantation create accessibility barriers, particularly in emerging economies with limited healthcare infrastructure. The invasive nature of certain procedures and associated complications, including infection risks and electrolyte imbalances, often deter patient compliance and physician recommendations.
Additionally, the lack of standardized treatment protocols across different healthcare systems and insufficient awareness about early diagnosis and management in certain regions pose considerable challenges. Despite these constraints, substantial opportunities exist within the market landscape. The increasing focus on personalized medicine and development of targeted therapies for underlying conditions causing ascites present lucrative prospects for pharmaceutical companies. Emerging markets in Asia-Pacific and Latin America offer significant expansion potential due to improving healthcare infrastructure and rising healthcare awareness.
Key Features of the Study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global ascites market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Baxter International, Fresenius Kabi, CSL Behring, Grifols SA, Pfizer Inc, Novartis AG, Otsuka Pharmaceutical, Bayer AG, AstraZeneca, Cook Medical, Boston Scientific, Medtronic, Becton Dickinson, Cardinal Health, and Teleflex
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global ascites market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global ascites market
Market Segmentation
- Ascites Type Insights (Revenue, USD Bn, 2021 - 2033)
- Transudative Ascites
- Exudative Ascites
- Malignant Ascites
- Chylous Ascites
- Hemorrhagic Ascites
- Infectious Ascites
- Ascites Severity Insights (Revenue, USD Bn, 2021 - 2033)
- Uncomplicated Ascites
- Recurrent/Refractory Ascites
- Treatment Type Insights (Revenue, USD Bn, 2021 - 2033)
- Medication (Diuretics, Albumin Therapy, Vasopressin Receptor Antagonists, Antibiotics, Targeted Cancer Therapy)
- Paracentesis (Therapeutic Paracentesis, Large-Volume Paracentesis, Image-Guided Paracentesis)
- Surgical Interventional Procedures (TIPS, Peritoneovenous Shunt, Indwelling Catheters & Drainage Systems)
- Others
- Clinical Grade Insights (Revenue, USD Bn, 2021 - 2033)
- Grade 1
- Grade 2
- Grade 3
- Route of Administration Insights (Revenue, USD Bn, 2021 - 2033)
- Oral
- Parenteral
- Distribution Channel Insights (Revenue, USD Bn, 2021 - 2033)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- End User Insights (Revenue, USD Bn, 2021 - 2033)
- Hospitals
- Specialty Clinics
- Ambulatory Surgical Centers
- Home Care Settings
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Baxter International
- Fresenius Kabi
- CSL Behring
- Grifols SA
- Pfizer Inc
- Novartis AG
- Otsuka Pharmaceutical
- Bayer AG
- AstraZeneca
- Cook Medical
- Boston Scientific
- Medtronic
- Becton Dickinson
- Cardinal Health
- Teleflex
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Ascites Market, By Ascites Type
- Global Ascites Market, By Ascites Severity
- Global Ascites Market, By Treatment Type
- Global Ascites Market, By Clinical Grade
- Global Ascites Market, By Route of Administration
- Global Ascites Market, By Distribution Channel
- Global Ascites Market, By End User
- Global Ascites Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Ascites Market, By Ascites Type, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Transudative Ascites
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Exudative Ascites
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Malignant Ascites
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Chylous Ascites
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Hemorrhagic Ascites
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Infectious Ascites
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
5. Global Ascites Market, By Ascites Severity, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Uncomplicated Ascites
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Recurrent/Refractory Ascites
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
6. Global Ascites Market, By Treatment Type, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Medication (Diuretics, Albumin Therapy, Vasopressin Receptor Antagonists, Antibiotics, Targeted Cancer Therapy)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Paracentesis (Therapeutic Paracentesis, Large-Volume Paracentesis, Image-Guided Paracentesis)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Surgical Interventional Procedures (TIPS, Peritoneovenous Shunt, Indwelling Catheters & Drainage Systems)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
7. Global Ascites Market, By Clinical Grade, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Grade 1
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Grade 2
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Grade 3
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
8. Global Ascites Market, By Route of Administration, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Parenteral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
9. Global Ascites Market, By Distribution Channel, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
10. Global Ascites Market, By End User, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Specialty Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Home Care Settings
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
11. Global Ascites Market, By Region, 2021 - 2033, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Ascites Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Ascites Severity, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Treatment Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Clinical Grade, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Ascites Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Ascites Severity, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Treatment Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Clinical Grade, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Ascites Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Ascites Severity, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Treatment Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Clinical Grade, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Ascites Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Ascites Severity, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Treatment Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Clinical Grade, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Ascites Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Ascites Severity, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Treatment Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Clinical Grade, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Ascites Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Ascites Severity, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Treatment Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Clinical Grade, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
12. Competitive Landscape
- Baxter International
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Fresenius Kabi
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- CSL Behring
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Grifols SA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Pfizer Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Novartis AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Otsuka Pharmaceutical
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bayer AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- AstraZeneca
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Cook Medical
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Boston Scientific
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Medtronic
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Becton Dickinson
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Cardinal Health
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Teleflex
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
13. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
14. References and Research Methodology
- References
- Research Methodology
- About us
